| Product Code: ETC6151400 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Overview |
3.1 Argentina Country Macro Economic Indicators |
3.2 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, 2021 & 2031F |
3.3 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market - Industry Life Cycle |
3.4 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market - Porter's Five Forces |
3.5 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders and chronic diseases in Argentina |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Advancements in mRNA technology and its potential for treating various diseases |
4.3 Market Restraints |
4.3.1 Regulatory hurdles and compliance requirements in the mRNA therapeutics sector in Argentina |
4.3.2 High costs associated with mRNA therapeutics development and manufacturing |
4.3.3 Limited expertise and infrastructure for mRNA therapeutics CDMO services in Argentina |
5 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Trends |
6 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market, By Types |
6.1 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, By Viral Vaccines, 2021- 2031F |
6.1.4 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, By Protein Replacement Therapies, 2021- 2031F |
6.1.5 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, By Cancer Immunotherapies, 2021- 2031F |
6.2 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.3 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, By Metabolic & Genetic Diseases, 2021- 2031F |
6.2.4 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, By Cardiovascular & Cerebrovascular Diseases, 2021- 2031F |
7 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Import-Export Trade Statistics |
7.1 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Export to Major Countries |
7.2 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Imports from Major Countries |
8 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Key Performance Indicators |
8.1 Number of clinical trials utilizing mRNA therapeutics in Argentina |
8.2 Investment in research and development for mRNA technology in the country |
8.3 Number of partnerships and collaborations between local and international pharmaceutical companies in the mRNA therapeutics sector in Argentina |
9 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market - Opportunity Assessment |
9.1 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market - Competitive Landscape |
10.1 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenue Share, By Companies, 2024 |
10.2 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here